These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 10893735)

  • 21. An open-label, noncomparative study of miglustat in type I Gaucher disease: efficacy and tolerability over 24 months of treatment.
    Pastores GM; Barnett NL; Kolodny EH
    Clin Ther; 2005 Aug; 27(8):1215-27. PubMed ID: 16199246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mental deterioration in old age: results of two multicenter, clinical trials with nimodipine. The Nimodipine Study Group.
    Parnetti L; Senin U; Carosi M; Baasch H
    Clin Ther; 1993; 15(2):394-406. PubMed ID: 8519047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rationale, design and methods of the OSCAR study: observational study on cognitive function and systolic blood pressure reduction in hypertensive patients.
    Pathak A; Hanon O; Negre-Pages L; Sevenier F;
    Fundam Clin Pharmacol; 2007 Apr; 21(2):199-205. PubMed ID: 17391293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Migraine prophylaxis with calcium antagonists: a haemodynamic study using transcranial Doppler ultrasound].
    Arjona A; Perula de Torres LA
    Rev Neurol; 2004 Feb 16-29; 38(4):316-9. PubMed ID: 14997453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of naftidrofuryl in patients with vascular or mixed dementia: results of a multicenter, double-blind trial.
    Emeriau JP; Lehert P; Mosnier M
    Clin Ther; 2000 Jul; 22(7):834-44. PubMed ID: 10945510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropsychological characteristics of mild vascular cognitive impairment and dementia after stroke.
    Stephens S; Kenny RA; Rowan E; Allan L; Kalaria RN; Bradbury M; Ballard CG
    Int J Geriatr Psychiatry; 2004 Nov; 19(11):1053-7. PubMed ID: 15481073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mild cognitive impairment with subcortical vascular features: clinical characteristics and outcome.
    Frisoni GB; Galluzzi S; Bresciani L; Zanetti O; Geroldi C
    J Neurol; 2002 Oct; 249(10):1423-32. PubMed ID: 12382161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The use of nimodipine in elderly dementia patients].
    Damulin IV; Levin OS; Zakharov VV; Zhuchenko TD; Elkin MN
    Ter Arkh; 1995; 67(10):77-9. PubMed ID: 8779117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The role of the age on the quality of life of patients older than 65 years of age with vertebrobasilar ischemia treated with nicardipine].
    Galiano L
    Rev Neurol; 1995; 23(122):784-8. PubMed ID: 7497240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The increase in erythrocyte deformability in patients treated with nicardipine or nimodipine.
    García-Alvarez F; Romero MS; al-Ghanem R; Calvo MT; Cortés M; Gutiérrez M
    Methods Find Exp Clin Pharmacol; 1993 Mar; 15(2):95-9. PubMed ID: 8487598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nicardipine versus propranolol in essential tumor.
    Jiménez-Jiménez FJ; Garcia-Ruiz PJ; Cabrera-Valdivia F
    Acta Neurol (Napoli); 1994 Aug; 16(4):184-8. PubMed ID: 7856472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Nicardipine and its indications in neurology].
    Moltó-Jordà JM; Matías-Guiu J
    Rev Neurol; 1997 Aug; 25(144):1235-41. PubMed ID: 9340158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neuromidin in the treatment of vascular cognitive disorders].
    Golovkova MS; Zakharov VV; Lifshits MIu; Iakhno NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(9):20-6. PubMed ID: 18379458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of Nicardipine After Cardiac Operations Is Safe in Children Regardless of Age.
    Stone ML; Kelly J; Mistry M; Buck M; Gangemi J; Vergales J
    Ann Thorac Surg; 2018 Jan; 105(1):181-185. PubMed ID: 28987396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis.
    Waters D; Lespérance J; Francetich M; Causey D; Théroux P; Chiang YK; Hudon G; Lemarbre L; Reitman M; Joyal M
    Circulation; 1990 Dec; 82(6):1940-53. PubMed ID: 2242520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy of prolonged therapy of vascular dementia].
    Klin Med (Mosk); 2011; 89(5):57-60. PubMed ID: 22242270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Nicardipine: a calcium antagonist for the treatment of arterial hypertension].
    Leonetti G
    Cardiologia; 1987 Jul; 32(7):613-7. PubMed ID: 3690586
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.